Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 83   

Articles published

NVO 47.82 +0.20 (0.42%)
price chart
Front Runners: The Boeing Company (NYSE:BA), Alcoa Inc (NYSE:AA), Novo ...
Las Vegas, NV - Aug 29, 2014 - (TechSonian) - ValuePennyStocks.com provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Related articles »  
Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares ...
Headquartered in Denmark, Novo Nordisk employs approximately. 40,700 employees in 75 countries, and markets its products in more than 180 countries.
Related articles »  
Shire's Drug To Put An End To Binge Eating
... few days after the FDA approved Orexigen Therapeutics, Inc.'s (OREX) weight-loss pill Contrave, the third weight-loss drug to gain approval in 13 years.
Related articles »  
Big Pharma: $100 Billion In Future Sales Expected
These late-stage drugs are expected to account for $100 billion in sales by 2018, for large pharmaceuticals like GlaxoSmithKline plc (ADR) (GSK), Novo Nordisk A/S (ADR) (NVO), and Sanofi SA (ADR) (SNY), according to Bloomberg Intelligence. Of these ...
Novo Nordisk A/S: Share repurchase programme
Headquartered in Denmark, Novo Nordisk employs approximately. 40,700 employees in 75 countries, and markets its products in more than 180 countries.
Arena Down On The Back Of Weigh-Loss Drug Failure
Arena has been unable to deliver on expectations of its weight-loss drug, Belviq. It has also been plagued with concerns of competition from soon-to-be launched weight loss drugs by Novo Nordisk A/S (ADR) (NVO) and Orexigen Therapeutics, Inc. (OREX).
Related articles »  
4 High-Profit Margin Stocks: Taiwan Semiconductor Mfg. Co. Ltd. (TSM), Rice ...
Novo Nordisk A/S (ADR) (NYSE:NVO) has 7% institutional ownership while its EPS ratio was 1.70. The company has 2.51B shares outstanding while market capitalization of the company was $ 100.19B.
Stocks in Focus � Novo Nordisk, (NYSE:NVO), NextEra Energy, (NYSE:NEE ...
Novo Nordisk A/S (ADR) (NYSE:NVO) decreased -1.24% and closed at $45.39 in the last trading session with the overall traded volume of 1.61 million shares, versus the average volume of 977,685 shares.
Related articles »  
Morning Buzz : Advanced Micro Devices (NYSE:AMD), Arena Pharmaceuticals ...
It has also been plagued with concerns of competition from soon-to-be launched weight loss drugs by Novo Nordisk A/S (ADR) (NVO) and Orexigen Therapeutics, Inc. (OREX). Return on Investment for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is -13.90% ...
Novo Nordisk A/S initiates share repurchase programme